Literature DB >> 1710169

Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies.

P Okunieff1, S Dols, J Lee, S Singer, P Vaupel, L J Neuringer, K Beshah.   

Abstract

Experimental tumors growing in irradiated tissue have been used to study the biological differences characteristic of locally recurrent tumors. Since the hypoxic cell fraction of tumors growing in irradiated tissue is increased and growth rate is slowed, these tumors are assumed to be metabolically deprived with hypoperfusion. In this study, we directly measured the effect of tumor bed irradiation on blood flow, growth rate, rate of nucleoside triphosphate (NTP) turnover, and metabolic state using 31P and 2H nuclear magnetic resonance, and an intradermal assay for angiogenesis. (NTP turnover refers to ATP-synthetase mediated NTP turnover that is visible to 31P nuclear magnetic resonance using the technique of saturation transfer.) A decrease in the number of small blood vessels perfusing tumors in a preirradiated bed was found. Most of the decrease was due to a loss of vessels with diameters less than 0.04 mm. When tumors growing in preirradiated tissue reached approximately 100 mm3 in volume, a high frequency of gross and microscopic necrosis and hemorrhage was already observed in most tumors. Consistent with these observations, the phosphocreatine/inorganic phosphate and nucleoside triphosphate/inorganic phosphate ratios were significantly lower in the tumors growing in a preirradiated bed compared with tumors in a nonirradiated bed. The blood flow rate was similar to control for tumors less than 100 mm3 (45.8 versus 40.5 ml/100 g/min, P = not significant), but was significantly lower than control for tumors greater than 100 mm3 (40.4 versus 12.2 ml/100 g/min, P less than 0.01). The NTP turnover rates correlated (P less than 0.005, r = 0.66) with the volume doubling rate (1/tumor volume doubling time), but for tumors approximately 100 mm3 in size neither the volume doubling rate nor the NTP turnover rate of tumors growing in an irradiated bed was statistically lower than control [NTP turnover: 14 +/- 3%/s versus 9 +/- 2%/s; volume doubling rate: 0.47 +/- 0.07/day versus 0.33 +/- 0.04/day (mean +/- SE)]. A large intertumor variability of all metabolic parameters was observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710169

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Acid-sensing ion channel 1 (ASIC1) mediates weak acid-induced migration of human malignant glioma cells.

Authors:  Yulan Sheng; Baoming Wu; Tiandong Leng; Li Zhu; Zhigang Xiong
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer.

Authors:  Seigo Kinuya; Kunihiko Yokoyama; Mishiroku Izumo; Takami Sorita; Takashi Obata; Hirofumi Mori; Kazuhiro Shiba; Naoto Watanabe; Noriyuki Shuke; Takatoshi Michigishi; Norihisa Tonami
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-09       Impact factor: 4.553

3.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Local hyperthermic treatment does not enhance mitoxantrone effectiveness for responses of a rat solid tumour regrowing after irradiation.

Authors:  C van Bree; E M Schopman; P J Bakker; J B Kipp; G W Barendsen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.

Authors:  Paul A Schornack; Robert J Gillies
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

7.  Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression.

Authors:  Yuichiro Tsuji; Naosuke Nonoguchi; Daisuke Okuzaki; Yusuke Wada; Daisuke Motooka; Yuki Hirota; Taichiro Toho; Nobuhiko Yoshikawa; Motomasa Furuse; Shinji Kawabata; Shin-Ichi Miyatake; Hiroyuki Nakamura; Ryohei Yamamoto; Shota Nakamura; Toshihiko Kuroiwa; Masahiko Wanibuchi
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

8.  The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.

Authors:  Thomas M Ashton; Emmanouil Fokas; Leoni A Kunz-Schughart; Lisa K Folkes; Selvakumar Anbalagan; Melanie Huether; Catherine J Kelly; Giacomo Pirovano; Francesca M Buffa; Ester M Hammond; Michael Stratford; Ruth J Muschel; Geoff S Higgins; William Gillies McKenna
Journal:  Nat Commun       Date:  2016-07-25       Impact factor: 14.919

9.  Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.

Authors:  Qian Xu; Qi Liu; Haitao Ge; Xinting Ge; Jiangfen Wu; Jianxun Qu; Kai Xu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.